# A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma

> **NCT01970358** · PHASE1 · COMPLETED · sponsor: **Patrick Ott, MD, PhD** · enrollment: 15 (actual)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** Poly-ICLC
- **BIOLOGICAL:** Peptides

## Key facts

- **NCT ID:** NCT01970358
- **Lead sponsor:** Patrick Ott, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-09
- **Final completion:** 2018-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970358, "A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01970358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*